West Lafayette, Indiana- based pharmaceutical company Endocyte has had its first drug recommended by approval by European Union regulators. The drug, Vynfinit, is an ovarian cancer treatment that has seen promising results in trials. Endocyte's stock shares nearly doubled as a result of the news.